Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public











Title  Creator  Group name  Publishing year 
[2021 update of the GEFPICS' recommendations for HER2 status assessment in invasive breast cancer in France] Franchet et al. EquipeELC 2021-08-12
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016 Deluche et al. EquipeCTCS 2020-04
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner Bianco et al. EquipeAM 02 22, 2019
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort Gobbini et al. EquipeCTCS Jun 2018
Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor Voisin et al. EquipeVC 10 31, 2017
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis Lefebvre et al. EquipeELC Dec 2016
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial Guiu et al. EquipeELC 2015
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model Trédan et al. EquipeELC Jun 2015
[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France] MacGrogan et al. EquipeELC Oct 2014
[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France] Penault-Llorca et al. EquipeELC Oct 2014


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés